Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23714 | 282 | 29.2 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1144 | 9108 | GLYCINE RECEPTOR//GABAA RECEPTOR//HYPEREKPLEXIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NOSCAPINE | Author keyword | 101 | 78% | 24% | 67 |
2 | NOSCAPINOIDS | Author keyword | 4 | 67% | 1% | 4 |
3 | BHUPAT JYOTI MEHTA BIOSCI BIOENGN | Address | 2 | 67% | 1% | 2 |
4 | BR AMBEDKAR BIOMED | Address | 2 | 27% | 2% | 7 |
5 | QUINUCLIDINE DERIVATIVES | Author keyword | 2 | 50% | 1% | 3 |
6 | 3 HYDROXY 1 AZABICYCLO222OCTANE 3 CARBOXYLATES | Author keyword | 1 | 100% | 1% | 2 |
7 | 9 BROMONOSCAPINE | Author keyword | 1 | 100% | 1% | 2 |
8 | ALPHA NARCOTINE | Author keyword | 1 | 100% | 1% | 2 |
9 | AMINO NOSCAPINE | Author keyword | 1 | 100% | 1% | 2 |
10 | BETA NARCOTINE | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOSCAPINE | 101 | 78% | 24% | 67 | Search NOSCAPINE | Search NOSCAPINE |
2 | NOSCAPINOIDS | 4 | 67% | 1% | 4 | Search NOSCAPINOIDS | Search NOSCAPINOIDS |
3 | QUINUCLIDINE DERIVATIVES | 2 | 50% | 1% | 3 | Search QUINUCLIDINE+DERIVATIVES | Search QUINUCLIDINE+DERIVATIVES |
4 | 3 HYDROXY 1 AZABICYCLO222OCTANE 3 CARBOXYLATES | 1 | 100% | 1% | 2 | Search 3+HYDROXY+1+AZABICYCLO222OCTANE+3+CARBOXYLATES | Search 3+HYDROXY+1+AZABICYCLO222OCTANE+3+CARBOXYLATES |
5 | 9 BROMONOSCAPINE | 1 | 100% | 1% | 2 | Search 9+BROMONOSCAPINE | Search 9+BROMONOSCAPINE |
6 | ALPHA NARCOTINE | 1 | 100% | 1% | 2 | Search ALPHA+NARCOTINE | Search ALPHA+NARCOTINE |
7 | AMINO NOSCAPINE | 1 | 100% | 1% | 2 | Search AMINO+NOSCAPINE | Search AMINO+NOSCAPINE |
8 | BETA NARCOTINE | 1 | 100% | 1% | 2 | Search BETA+NARCOTINE | Search BETA+NARCOTINE |
9 | EM011 | 1 | 100% | 1% | 2 | Search EM011 | Search EM011 |
10 | EM012 | 1 | 100% | 1% | 2 | Search EM012 | Search EM012 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PERTURB MITOSIS | 90 | 96% | 10% | 27 |
2 | NOSCAPINE | 28 | 60% | 11% | 31 |
3 | NARCOTINE | 9 | 83% | 2% | 5 |
4 | H 3 NOSCAPINE | 8 | 100% | 2% | 5 |
5 | PITRAZEPIN | 6 | 100% | 1% | 4 |
6 | CARBAMOYL N THIOCARBAMOYL NARCOTINE | 2 | 67% | 1% | 2 |
7 | TUSSIVE AGENT NOSCAPINE | 2 | 67% | 1% | 2 |
8 | UNDERGO APOPTOSIS | 2 | 18% | 3% | 8 |
9 | 5 ISOXAZOLOL ZWITTERIONS | 1 | 100% | 1% | 2 |
10 | GNOSCOPINE | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Taking aim at a dynamic target: Noscapinoids as microtubule-targeted cancer therapeutics | 2015 | 2 | 37 | 62% |
The Anti-Cancer Activity of Noscapine: A Review | 2009 | 38 | 34 | 79% |
A Review on Noscapine, and its Impact on Heme Metabolism | 2013 | 6 | 41 | 59% |
Implications of Nanoscale Based Drug Delivery Systems in Delivery and Targeting Tubulin Binding Agent, Noscapine in Cancer Cells | 2012 | 6 | 43 | 58% |
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications | 2015 | 0 | 87 | 75% |
Microtubule-interacting drugs for cancer treatment | 2003 | 86 | 49 | 12% |
Comparison of binding mechanisms at cholinergic, serotonergic, glycinergic and GABAergic receptors | 1996 | 19 | 30 | 27% |
Nanosolvated microtubule-modulating chemotherapeutics: a case-to-case study | 2013 | 0 | 65 | 17% |
Pitrazepin: Interactions with transmitter receptors of the central and peripheral nervous systems | 2000 | 0 | 40 | 20% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BHUPAT JYOTI MEHTA BIOSCI BIOENGN | 2 | 67% | 0.7% | 2 |
2 | BR AMBEDKAR BIOMED | 2 | 27% | 2.5% | 7 |
3 | BIZIM LOSEMILI COCUKLAR VAKFI | 1 | 50% | 0.4% | 1 |
4 | EXPT CANC THER EUT CHEM BIOL | 1 | 50% | 0.4% | 1 |
5 | OFF NEW DRUG CLIN TRIALS | 1 | 50% | 0.4% | 1 |
6 | K M | 0 | 33% | 0.4% | 1 |
7 | CEQUINOR QUIM | 0 | 25% | 0.4% | 1 |
8 | RAT DRUG USE | 0 | 25% | 0.4% | 1 |
9 | OUR CHILDREN LEUKEMIA FDN | 0 | 20% | 0.4% | 1 |
10 | RASOOL AKRAM MED | 0 | 20% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000084309 | GAS COAL AIR PROTECT//GENERAL FEED MIXTURES//PLANT ANAL |
2 | 0.0000075904 | NASAL PROVOCATION TEST NPT//ACUTE TOXICITY STUDY LIMIT TEST//BURKARD POLLEN TRAP |
3 | 0.0000070350 | CNRS BIOCHIM THEOR//AUTOSTEREOGRAM//TRANSFORMATION OF DATA |
4 | 0.0000060004 | AB INITIO QUANTUM MECHANICAL//NITROSTYRENE DERIVATIVES//SEMIEMPIRICAL QUANTUM MECHANICAL |
5 | 0.0000059696 | COMBRETASTATIN//COMBRETASTATIN A 4//COMBRETASTATINS |
6 | 0.0000058229 | BOVINE SERUM ALBUMIN NANOPARTICLES//HUMAN SERUM ALBUMIN NANOPARTICLES//COACERVATION METHOD |
7 | 0.0000057579 | TIAGABINE//GABA UPTAKE INHIBITORS//GABA UPTAKE |
8 | 0.0000056104 | HEMATOL ONCOLWINSHIP CANC//MICROTUBULE ACTIVE DRUGS//PHARMACOLRAMMELKAMP EDUC |
9 | 0.0000052900 | CASIMIROA EDULIS//CASIMIROA PUBESCENS//CASIMIROA PRINGLEI |
10 | 0.0000048460 | 3 N BUTYLPHTHALIDE//DL 3 N BUTYLPHTHALIDE//L 3 N BUTYLPHTHALIDE |